Our findings show significant alterations in lipid metabolism in astrocytes during AD progression, challenging the traditional view that AD pathology is primarily driven by the abnormal accumulation of β‐amyloid and tau proteins. The gene discussed is MAPT; the disease is Alzheimer disease.